Latest guidance  

Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer
Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal)
Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
Flu vaccination: increasing uptake

Latest guidance in consultation  

Ustekinumab for treating moderately to severely active ulcerative colitis [ID1511]
Multiple sclerosis in adults: management
Community pharmacies: promoting health and wellbeing
Indoor air quality at home
Larotrectinib for treating advanced solid tumours with TRK fusions [ID1299]

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

Latest news  

  1. NICE encourages further data collection on ‘game changing’ histology independent cancer drugs
  2. Make use of community pharmacists’ skills, says NICE
  3. Breast cancer patients to have further NICE-approved drug combination option on Cancer Drugs Fund
  4. Implantable cardiac monitors detect atrial fibrillation after stroke of unknown cause recommended for routine NHS adoption

Tweets

by @NICEcomms